FCG Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

FCG Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.56M	Buy	41,073 +6,612	+19%	+$418K	0.84%	28
2026 Q2	$1.99M	Buy	34,461 +26,082	+311%	+$1.5M	0.69%	39
2026 Q1	$508K	Buy	+8,379	New	+$488K	0.22%	75
2025 Q3	$609K	Buy	13,493 +3,471	+35%	+$162K	0.28%	65
2025 Q2	$464K	Sell	10,022 -530	-5%	-$26K	0.24%	76
2025 Q1	$644K	Buy	+10,552	New	+$615K	0.4%	62
2024 Q2	–	Sell	-8,212	Closed	-$445K	–	94
2024 Q1	$445K	Buy	+8,212	New	+$418K	0.36%	78

Other funds holding BMY

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

FCG Investment Company's BMY Position: Q3 2026 in Review

FCG Investment Company increased its Bristol-Myers Squibb (BMY) stake by 19% in Q3 2026, buying an estimated $418K and bringing the position to 41,073 shares worth $2.56M. The position accounts for 0.84% of the portfolio, ranked #28.

FCG Investment Company first reported a position in BMY in Q1 2024 and has held it in 7 quarters since. 368 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

FCG Investment Company held 41,073 shares of Bristol-Myers Squibb worth $2.56M as of Q3 2026.
FCG Investment Company bought 6,612 Bristol-Myers Squibb shares in Q3 2026, an estimated $418K.
Bristol-Myers Squibb made up 0.84% of FCG Investment Company's portfolio in Q3 2026, its #28 holding.
FCG Investment Company first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 7 quarters since.
368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on FCG Investment Company's 13F filing for Q3 2026, filed 13 Oct 2026.